Digi tech pharma-2017

MORE TOP SPEAKERS JOINING OUR LINE UP SOON.

OUR PROMINENT SPEAKERS

VP-Head Strategic Planning and Digital Practices, Global Medical Affairs

TIMCAVE

GlaxoSmithKline

Global Vice PresidentHealth Sciences

JONATHAN SHELDON

Oracle

Director Multichannel Management

SUSANNE KELLENAERS

Daiichi Sankyo

Digital Lead for Medical Affairs & PRA – Europe & Canada

NADEEM ASHRAF

Eli Lilly and Company

Corporate Communications Specialist

CARLA ARRIETA

Roche Diabetes Care

Regional Client Partner

ANAND DAS

Pfizer

Director Emerging Technology

PETER WAGGETT

IBM

Technology Incubation Lab

SPEAKER TBC

AstraZeneca Marketing Manager

PELIN ICIL

Bayer

Head of TDA Europe and Canada

STEPHANIE BOVA

Takeda Pharmaceuticals Europe

Strategy & Operations Director

TUGHAN DEMIRBILEK

Bristol-Myers Squibb

Head of Healthcare, IoT Vertical Market Development

JON LEE-DAVEY

Vodafone

Patient Care Solution Lead

HERVE DUMAS

UCB

Product Owner

PAUL JACOBS

Leo Innovation Lab

DIGI-TECH PHARMA 2017

TH TH25 AND 26 APRIL 2017 HOTEL NOVOTEL LONDON CITY SOUTHLONDON, UNITED KINGDOM.

"EMERGENCE OF DIGITAL TECHNOLOGIES IN PHARMACEUTICAL INDUSTRY"

Head of pvtech

MARTIN HOLMPETERSEN

Navitas Life Sciences

CORVUS

www.corvusglobalevents.com [email protected] +44 (0) 207 096 0786

European Innovation Lead

DUNCAN ARBOUR

inVentiv Health

Head of TDA for R&D

MAGDELENA SCHOENEICH

Takeda Pharmaceuticals Europe


TH TH25 AND 26 APRIL 2017, HOTEL NOVOTEL LONDON CITY SOUTH LONDON, UNITED KINGDOM.

CONFERENCE FOCUS

Gone are the days when pharma companies were associated with just selling the drugs. With more

competitions, a revolution in healthcare, and an increase in general public understanding of health, pharma

companies are trying hard to keep up with the changing technologies. About 70% of patients use the

internet to obtain information on health, treatment regime, drug safety and efficacy. This certainly imposes a

threat that patients may reject a drug or treatment they consider expensive and not effective. It is thus

inevitable to disregard this changing environment. Cloud computing, Internet of things, Big data and

translational Informatics are transforming the world and pharma industries not immune to this change. The

pharma has been relatively in moving from business-to-business model to a business-to- consumer model,

though few have finally accepted this trend and has been making progress in the digital transformation to

bring the consumers closer them. But there still exists numerous challenges that the companies have to

face during this transformation. There is still an uncertainty about the success of digitization. Unless the

pharma companies are able to come up with strategies to keep up with the digital revolution, they may lose

the market and customer base to new innovative entrants in the field.

Digital Pharma World 2017, will provide a platform to all its participants an opportunity to interact, share and

discuss the digitalization of Pharma industry. It will allow its participants to discuss the various challenges

faced, new strategies, case studies and use of innovative ideas in the field of digital pharma. Also, to stay

updated on the latest trends in digital, social media and mobile strategies required the overcome the

obstructions in the transformation. This conference will allow IT leaders to share their technologies and

strategies to help the pharma industries. The conference will offer opportunities to encourage partnerships

and collaborations It gives us a great pleasure to welcoming you to the Digi-Tech Pharma 2017.

KEY HIGHLIGHTS

Digitally enabled business models

Big data analytics and pharma

Internet of things and pharma

Translational Informatics

Policy changes required for ensuring smooth transition

Ensuring regulatory compliance during the transformation

Digital marketing trends

Integrating Multichannel marketing and closed loop marketing

Digitalization of R& D using Big Data and IoT

New smart devices in manufacturing and supply chain

Clinical trials and digital world

Data management

Tools and strategies to engage with HCPs and patients

and to win their confidence

Encouraging a customer–centric approach at all levels

Unrealized innovative potentials of digital era that pharma needs

to focus on

WHO SHOULD ATTEND THE CONFERENCE

GET IN TOUCH WITH THE TEAM

CORVUS


WANT TO SPEAK?please e-mail to

[email protected]

WANT TO SPONSOR OR [email protected]

MEDIA & PARTNERSHIP [email protected]

This event is designed for senior level attendees from various companies

including pharmaceutical, biotechnological, biopharmaceutical, CRO’s,

Diagnostics, solution provider and government institutions.

Attendees includes VPs, GMs, Directors, Heads and Managers of

Ÿ Pharma sales and Marketing Ÿ E-marketingŸ Digital innovative strategic

planningŸ Regulatory and

pharmacovigilanceŸ IT consultantsŸ Clinical trials and data

management

Ÿ Translational informaticsŸ Data storage and analysisŸ Contract outsourcing service providersŸ Multi-channel ManagementŸ Health care professionalsŸ Health IT professionalsŸ IT consultants

Ÿ Company leadership and transformation

Ÿ Need for communication specialists and up-to-date

technologies

Ÿ Hiring digital experts and collaborations

Ÿ The need to be really quick in transforming at every level

Registration & Morning Coffee08:30

CONFERENCE SCHEDULE

THDAY 1 - 25 April 2017

Chairperson's opening remarks09:20

A decade of digital pharma 2006 - 2017: How far have we reached and the path forward?

09:30

CHANGING HEALTH & DIGITAL WORLD

TIM CAVEVP-Head Strategic Planning and Digital Practices, Global Medical Affairs, GlaxoSmithKline (UK)

Transforming the organization by transforming to digital: A tough road ahead….

10:00

Networking and Refreshment Break10:30

Ÿ What is the impact of digital on health economies?

Ÿ How do Payers see digital in delivering health care (reducing

costs and improving outcomes)?

Ÿ Examine the needs and challenges of payers and review the

existing NHS policy framework and future trends in digital in relation to payers.

Ÿ What strategy has Eli Lilly and company adopted to align with

payers’ needs – and what are opportunities for pharma in this context?

The healthcare payers are undergoing a transformation that is materially impacting the way they evaluate medications and develop formularies.Pharmaceutical companies need to adapt to their changing needs to continue to be successful.

10:50

Networking and Luncheon12:20

The Global Technology Outlook and its impact on the pharma industry

11:50

CORVUS


Ÿ The changing patient behavior in the digital era

Ÿ Why is it essential to be prompt in identifying and addressing

the patients needs?

Ÿ How will digitization help bring patients on board?

Ÿ Progress made by companies so far

Ÿ Strategies to be adopted to increase patient –company data

flow

Importance of patient engagement in R&D: Beneficial or just a hype?

13:30

PETER WAGGETT Director Emerging Technology, IBM (UK)

NADEEM ASHRAFDigital Lead for Medical Affairs & PRA – Europe & Canada, Eli Lilly and Company (UK)

Ÿ What are the barriers that industry are facing today? – and

where are the Regulators?

Ÿ Will big data / digital health and cognitive computing

improve patient safety?

Ÿ How will a digitally transformed future shape the

relationship between stakeholders?

A road towards digitally transformed Pharmacovigilance11:20

CHANGING HEALTH & DIGITAL WORLD

MARTIN HOLM-PETERSENHead of pvtech, Navitas Life Sciences (Denmark)

Ÿ Progresses made towards digital transformation: Was it a

smooth ride?

Ÿ Challenges conquered by the industry

Ÿ Digitally enabled business models

Ÿ Learning from other industries and verticals

CARLA ARRIETACorporate Communications SpecialistRoche Diabetes Care (Spain)

Digitalization and R&D

Ÿ Importance of big data in decision making

Ÿ Paying attention on treatments for rare diseases

Ÿ Need for data integration and collaborations for free flow of

information

Big data analytics in Pharma: Reshaping the R&D14:00

Challenges in Big data and digital health transformation and the way forward

14:30

Ÿ Reluctance to adopt digital in R & D

Ÿ Breaking the age old conservative habits of pharma

Ÿ Data integrationCreating digitally empowered work force

JONATHAN SHELDONGlobal Vice President,Health Sciences, Oracle (UK)

Afternoon Tea/Coffee15:00

Translational informatics and precision medicine15:30

Ÿ Importance of Translational informatics in R&D

Ÿ Why is it necessary to adopt TI in the resource – constrained

world?

Ÿ Major purpose of using TI by the industry

Ÿ Challenges ahead and moving forward



Ÿ What could the evolution of IoT impact patients care

experience?

Ÿ How can IoT change the HCP-Patients interaction?

Ÿ Can it change the way we see real word evidence

generation?

IoT and connected patients transformation14:30

Networking Lucheon12:20

Catalysing Innovation in Pharma IT13:30

SPEAKER TBCTechnology Incubation Lab, AstraZeneca (UK).

CORVUS


Chairperson's closing remarks16:50

Networking Drinks Session17:00

Registration & Morning Coffee08:30

Chairperson's opening remarks09:20

THDAY 2 - 26 APRIL 2017

Ÿ Web-based marketing strategies

Ÿ Using web-advertising, video cast,podcast and other

techniques for customer outreachHas web marketing increased the brand value?

Ÿ Increasing effective communication using Web marketing

Case Study: Online marketing and pharmaceutical industry09:30

PELIN ICILMarketing Manager, Bayer HealthCare Pharmaceuticals (Turkey)

Digital Marketing

7 Steps to Success in Digital Pharma Marketing10:00

TUGHAN DEMIRBILEKIStrategy & Operations Director, Bristol-Myers Squibb (Turkey)



Ÿ Benefits of collaborations

Ÿ The best emerging practices in collaboration

Ÿ Strategies for efficient collaboration

Collaboration with third party service providers- A way ahead?15:30

Ÿ Are we only focusing on customers while transforming to

digital?

Ÿ Drawbacks of being only customer-centric

Ÿ Identifying others areas that need to be looked atInnovations

key to the future

Panel discussion: Digitalization: Is it all about only Customer engagement or do we have to think and move beyond?

16:00

Chairperson's closing remarks and end of conference16:50

PAUL JACOBSProduct Owner, Leo Innovation Lab (UK)

MAGDELENA SCHOENEICHHead of TDA for R&D, Takeda PharmaceuticalsEurope (Switzerland)

Ÿ Impact of IoT and Cloud on clinical research

Ÿ Obstacle and complexities involved especially from the

patient point of view

Ÿ .How do we balance transparency, free flow of data and

patient privacy? Where do we draw the line?

Panel discussion: With huge data reserve and unparalleled flow of information are we jeopardizing patient privacy and infidentiality

16:00

ANAND DAS,Regional Client Partner, Pfizer (UK).

Ÿ Benefits of integrating CLM and MCM

Ÿ Strategies to combine CLM and MCM

Ÿ Challenges that needs to be succeeded

Integrating Multichannel marketing and closed loop marketing- Is it the future of digital marketing?

10:50

SUSANNE KELLENAERSDirector Multichannel Management, Daiichi Sankyo Europe GmbH (Germany)

Ÿ Long-term impact of social media and mobile technologies

Ÿ Enhancing brand value through social media

Ÿ Current trends and innovative technologies and effectively

measuring ROI

Ÿ Managing the regulatory system

Effectively using social media and mobile marketing11:20

Network Provider’s Perspective

IoT & Network Solutions (Topic TBC)11:50

JON LEE-DAVEYHead of Healthcare, IoT Vertical Market Development, Vodafone (UK)

Customer - centric Digital Health: Future & Innovations

How pharma needs to think about bots and AI14:00

STEPHANIE BOVAHead of TDA Europe and Canada, Takeda Pharmaceuticals Europe (Switzerland).

HERVE DUMASPatient Care Solution Lead,UCB (Switzerland).

DUNCAN ARBOUREuropean Innovation Lead, inVentiv Health (UK)



CORVUS

SPONSORSHIP OPPORTUNITIES

ASSOCIATE SPONSOR

MEDIA PARTNER

Maximise Your Involvement through Sponsorship and Exhibition Opportunities Our Sponsors are an integral part of the CGE Conference and we want to ensure you receive the best possible results for your investment. Exhibiting and Sponsorship options are extensive, and packages can be tailor-made to suit your individual company's needs. Most packages include complimentary entry passes, targeted marketing to industry officials and executives, and bespoke networking opportunities.

Exhibiting and Sponsorship options are extensive, and packages can be tailor-made to suit your individual company’s needs. .

Maximise Your Involvement : Sponsorship and Exhibition Opportunities

For more information : Please contact : +44 (0) 207 096 0786 or email : [email protected]

www.corvusglobalevents.com [email protected] +44 (0)20 7017 5506www.corvusglobalevents.com [email protected] +44 (0) 207 096 0786

PLD SPONSOR



DELEGATE REGISTRATION FORM

Pass Types :

Team Discounts

Total No of Delegate

Price

Price

Price

Super Early Bird Pass Options ( till Jan 01st )

Early Bird Pass Options ( till March 01st )

Standard Pass Options ( till April 24th )

Collateral Pack in Delegate Tote Bag

Super Early Bird Single

Early Bird Single

Standard Pass Single

Super Early Bird Group ( 3 for 2 )

Early Bird Group ( 3 for 2 )

Standard Pass Group ( 3 for 2 )

£ 580 + VAT

£ 699 + VAT

£ 950 + VAT

£ 1160 + VAT

£ 1398 + VAT

£ 1900 + VAT

£ 650 + VAT

Bring your team and get an extra discount. There are special group packages available. Please email to [email protected] for more details.

For Registering more than 1 delegate kindly send the details of all the delegates through email with the copy of this registration form

For Registration or more infomation on the Program please call at +44 (0) 207 096 0786 Email : [email protected]

Visa Master American Express Invoice me

Expiry Date :

Payment Options :

Check : ( Make checks payable to the Corvus Global Events )

Card Type :

Security No :

Card Holder Name :

Card Holder Signature :

Billing Address :

Card Number :

Invoice Details :

Name :

Comapany Name :

Address :

City :

State :

Email :

Mobile :

Zip Code :

Country :

Delegate Details :

Name :

Comapany Name :

Jop Tittle :

Address :

Mobile No :

Email id :

TERMS & CONDITIONS PAYMENTPayment TermsAll bookings made prior to the conference must be paid in full to guarantee registration. Payment can be made through booking via credit card, debit card, bank transfer or cheque payment. Once payment has been received, an email confirmation and a receipted invoice will be sent. If payment is not made at the time of booking, registration will be provisional. If you apply to register for the conference less than two (2) weeks before the date of the conference we will only accept payment by a credit card, unless we expressly agree otherwise in writing.

Cancellation or Substitution PolicySubstitutions are allowed with the written permission of the original registrant up to 48 hours prior to the start of the event, at no extra charge. Should substitution not be possible, cancellation can be done subject to an administrative fee.

CORVUS


Bank Details : Account Name : CORVUS GLOBAL EVENTS LIMITED

Account Number : 21370568Bank Name : Lloyds BANK

Sort Code : 30-96-26

SWIFT/BIC Code : LOYDGB21446

IBAN : GB64LOYD30962621370568For Cheque : Payable to Corvus Global Events Limited.

